Kymera Therapeutics Inc (KYMR)

Other Income/Expenses (Net)

$14.40M

Quarterly · Period ending: · USD

KYMR logo

KYMR Other Income/Expenses (Net)

Latest reported$14.40M
KYMR Quarterly Other Income/Expenses (Net) ($441.00K → $14.40M)
High-resolution chart · PNG

KYMR other income/expenses (net) history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Kymera Therapeutics Inc Other Income/Expenses (Net) — Quarterly (USD)
Period endingOther Income/Expenses (Net) (USD)
14,396,000
14,920,000
10,643,000
10,346,000
7,943,000
8,845,000
10,003,000
9,637,000
8,863,000
9,274,000
4,944,000
4,642,000
4,584,000
4,398,000
3,765,000
1,880,000
553,000
249,000
94,000
55,000
70,000
94,000
97,000
97,000
203,000
315,000
270,000
441,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.